SaferWorldbyDesign Webinar: A novel in vitro approach for quantitative assessment of skin sensitizing potency

This presentation will introduce GARDskin Dose-Response assay, a novel approach for the assessment of relative skin sensitizing potency on a continuous scale. Results demonstrate that induction of toxicity pathways in GARDskin Dose-Response appears to be highly dose-dependent, and the lowest concentration required to induce a positive classification in the assay correlates strongly and significantly with […]

WC11

11th World Congress on Alternatives and Animal Use in the Life Sciences 23 August - 2 September 2021 | Virtual Congress   Posters open for viewing: Aug 10 - Sep 2 # P471 Abstract ID 961 Quantitative sensitizing potency assessment using GARDskin Dose-Response Dr Henrik Johansson # P140 Abstract ID 334 The GARDpotency assay for […]

Webinar: How is GARD used for skin sensitization testing?

User cases on hazard and potency assessment Given the huge interest in our previous webinar on GARD user cases, we are pleased to offer you a new opportunity to hear how our customers use GARD to fill data gaps in sensitizing hazard and potency assessment of chemicals and medical devices. Key topics We will provide […]

Eurotox

Eurotox 2021 Virtual Congress 27 September - 1 October   🌎Industry symposium hosted by SenzaGen Sep 29, 17.30 - 18.30 Filling data gaps in skin sensitization testing: in vitro hazard and potency assessments using GARD Dr Andy Forreryd Dr Henrik Johansson GARDskin and GARDpotency: a proof of concept study to investigate the applicability domain for […]

Cosmetic 360

Paris, France

The international innovation fair for cosmetic and perfume industry October 13-14 | Carrousel du Louvre, Paris | Booth: S4 Meet SenzaGen and partners PKDerm, GenEvolutioN, WatchFrog and CEHTRA at Cosmetic 360, the international innovation fair for the cosmetic and perfume industry, to find out about our latest innovations for safety and efficacy evaluation of cosmetics and ingredients. […]

Webinar: Safer Medical Devices – In Vitro Assays As Part of a Biological Evaluation

In this webinar, the speakers will discuss the uses of in vitro assays as a part of the risk assessment and biological evaluation for the following endpoints: cytotoxicity, skin irritation and skin sensitization. Key topics The presentation will introduce biological evaluation and biocompatibility testing of medical devices, with focus on in vitro assays for skin irritation and skin sensitization now implemented in […]

Webinar: Recap on SenzaGen’s Eurotox Industry Symposium

Filling data gaps in skin sensitization testing: In vitro hazard and potency assessment using GARD In case you missed SenzaGen's industry symposium at this year's Eurotox Virtual Congress, here is a new opportunity! Together with guest speakers from Corteva Agriscience and Essity Hygiene & Health, we will present customer cases where the in vitro GARD assays have […]

Webinar: Safety Testing of Cosmetic Products

An Overview of Established Methods and New Approach Methodologies (NAMs) In this joint webinar,  we will present an overview of established methods and New Approach Methodologies (NAMs) used in the safety testing of cosmetic products. The webinar will start with a recorded presentation followed by a live Q&A session. If you cannot attend the live […]

New Approach Methodologies for Medical Devices

NAMs for Medical Devices: Use of New Approach Methodologies for the Biological Safety Assessment of Medical Devices Join New Approach Methodology Use for Regulatory Application (NURA) on December 2 to learn how you can use the latest in vitro methods for Biological Safety Assessment of medical devices. Engage with industry experts and the Center for […]